Breaking

muscular dystrophy

User Blocked by Social Media Platform
Research Drops

User Blocked by Social Media Platform

FDA rejects Capricor's deramiocel for Duchenne muscular dystrophy treatment due to lack of effectiveness evidence, based on phase 3 trial findings.

Zenobia Fairweather · July 31, 2026